{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:51:57Z","timestamp":1790815917779,"version":"4.1.0"},"reference-count":128,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007475","name":"Clermont Universit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007475","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-14-CE12-0007"],"award-info":[{"award-number":["ANR-14-CE12-0007"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","award":["PJA 20141201894"],"award-info":[{"award-number":["PJA 20141201894"]}],"id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2016.00093","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T23:03:01Z","timestamp":1468537381000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Mouse Models Recapitulating Human Adrenocortical Tumors: What Is Lacking?"],"prefix":"10.3389","volume":"7","author":[{"given":"Felicia","family":"Leccia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Batisse-Lignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Sahut-Barnola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Val","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A-Marie","family":"Lefran\u00e7ois-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000134829","article-title":"Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin-independent Cushing syndrome)","volume":"13","author":"Stratakis","year":"2008","journal-title":"Endocr Dev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"M99","DOI":"10.1530\/EJE-15-0353","article-title":"cAMP signaling in cortisol-producing adrenal adenoma","volume":"173","author":"Calebiro","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"162804","DOI":"10.4061\/2011\/162804","article-title":"Changes in the perceived epidemiology of primary hyperaldosteronism","volume":"2011","author":"Fagugli","year":"2011","journal-title":"Int J Hypertens"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1210\/jc.2009-0516","article-title":"Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors","volume":"94","author":"Hsiao","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1210\/jc.2008-2333","article-title":"Mutations in regulatory subunit type 1A of cyclic adenosine 5\u2019-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes","volume":"94","author":"Bertherat","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4711::AID-CNCR13.0.CO;2-W","article-title":"Adrenocortical carcinoma: clinical and laboratory observations","volume":"88","author":"Wajchenberg","year":"2000","journal-title":"Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mce.2011.10.019","article-title":"Molecular epidemiology of adrenocortical tumors in southern Brazil","volume":"351","author":"Cust\u00f3dio","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal Cushing\u2019s syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with Cushing\u2019s syndrome","volume":"369","author":"Assi\u00e9","year":"2013","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat Genet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/eje.0.1490273","article-title":"Prevalence and natural history of adrenal incidentalomas","volume":"149","author":"Barzon","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1530\/EJE-09-0234","article-title":"Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?","volume":"161","author":"Cawood","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1530\/EJE-15-0199","article-title":"The clinical course of patients with adrenal incidentaloma: is it time to reconsider the current recommendations?","volume":"173","author":"Kastelan","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1210\/jc.2002-021117","article-title":"A case report in favor of a multistep adrenocortical tumorigenesis","volume":"88","author":"Bernard","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e73959","DOI":"10.1371\/journal.pone.0073959","article-title":"Single nucleotide polymorphism array profiling of adrenocortical tumors \u2013 evidence for an adenoma carcinoma sequence?","volume":"8","author":"Ronchi","year":"2013","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"9327","DOI":"10.1093\/nar\/gkv908","article-title":"Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples","volume":"43","author":"Gara","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"E301","DOI":"10.1210\/jc.2011-1588","article-title":"Clinical and pathophysiological implications of chromosomal alterations in adrenocortical tumors: an integrated genomic approach","volume":"97","author":"Barreau","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0925-4773(03)00039-X","article-title":"Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs","volume":"120","author":"Bertolino","year":"2003","journal-title":"Mech Dev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1073\/pnas.98.3.1118","article-title":"A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors","volume":"98","author":"Crabtree","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1158\/0008-5472.CAN-05-0580","article-title":"A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues","volume":"65","author":"Kirschner","year":"2005","journal-title":"Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/jmg.2004.028043","article-title":"A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions","volume":"41","author":"Griffin","year":"2004","journal-title":"J Med Genet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1000980","DOI":"10.1371\/journal.pgen.1000980","article-title":"Cushing\u2019s syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice","volume":"6","author":"Sahut-Barnola","year":"2010","journal-title":"PLoS Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1124\/mol.110.069104","article-title":"The high-affinity cAMP-specific phosphodiesterase 8B controls steroidogenesis in the mouse adrenal gland","volume":"79","author":"Tsai","year":"2011","journal-title":"Mol Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/hmg\/ddq029","article-title":"Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development","volume":"19","author":"Berthon","year":"2010","journal-title":"Hum Mol Genet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ajpath.2012.05.026","article-title":"Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and \u03b2-catenin","volume":"181","author":"Heaton","year":"2012","journal-title":"Am J Pathol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1210\/endo.140.4.6660","article-title":"Postnatal overexpression of insulin-like growth factor II in transgenic mice is associated with adrenocortical hyperplasia and enhanced steroidogenesis","volume":"140","author":"Weber","year":"1999","journal-title":"Endocrinology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e44171","DOI":"10.1371\/journal.pone.0044171","article-title":"Analysis of the role of Igf2 in adrenal tumour development in transgenic mouse models","volume":"7","author":"Drelon","year":"2012","journal-title":"PLoS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ccr.2009.04.011","article-title":"Genetic p53 deficiency partially rescues the adrenocortical dysplasia phenotype at the expense of increased tumorigenesis","volume":"15","author":"Else","year":"2009","journal-title":"Cancer Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1210\/mend.10.12.8961275","article-title":"Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter\/simian virus 40 T-antigen fusion gene: evidence for negative autoregulation of the inhibin alpha-subunit gene","volume":"10","author":"Kananen","year":"1996","journal-title":"Mol Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3109\/07435800009048613","article-title":"Adrenal tumorigenesis targeted by the corticotropin-regulated promoter of the aldo-keto reductase AKR1B7 gene in transgenic mice","volume":"26","author":"Sahut-Barnola","year":"2000","journal-title":"Endocr Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1210\/me.2007-0120","article-title":"Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer","volume":"21","author":"Doghman","year":"2007","journal-title":"Mol Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.beem.2008.10.011","article-title":"ACTH-independent macronodular adrenal hyperplasia","volume":"23","author":"Lacroix","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/ncpendmet0648","article-title":"Genetics of adrenal tumors associated with Cushing\u2019s syndrome: a new classification for bilateral adrenocortical hyperplasias","volume":"3","author":"Stratakis","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1210\/jcem-24-10-947","article-title":"Cushing\u2019s syndrome: nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor","volume":"24","author":"Kirschner","year":"1964","journal-title":"J Clin Endocrinol Metab"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1056\/NEJMoa1215245","article-title":"Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia","volume":"369","author":"Louiset","year":"2013","journal-title":"N Engl J Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1530\/eje.1.02324","article-title":"Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors","volume":"156","author":"Vezzosi","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1148\/radiol.2443041507","article-title":"Case 121: familial adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing syndrome","volume":"244","author":"Watson","year":"2007","journal-title":"Radiology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"E1501","DOI":"10.1210\/jc.2013-4237","article-title":"ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia","volume":"99","author":"Alencar","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1210\/edrv.22.1.0420","article-title":"Ectopic and abnormal hormone receptors in adrenal Cushing\u2019s syndrome","volume":"22","author":"Lacroix","year":"2001","journal-title":"Endocr Rev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1210\/jcem.86.11.8062","article-title":"Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing\u2019s syndrome","volume":"86","author":"Bourdeau","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.tem.2004.08.007","article-title":"Cushing\u2019s syndrome variants secondary to aberrant hormone receptors","volume":"15","author":"Lacroix","year":"2004","journal-title":"Trends Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJM199210013271403","article-title":"Food-dependent Cushing\u2019s syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide","volume":"327","author":"Reznik","year":"1992","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1210\/jcem.87.5.8458","article-title":"The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors","volume":"87","author":"Groussin","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJM199911183412104","article-title":"Leuprolide acetate therapy in luteinizing hormone \u2013 dependent Cushing\u2019s syndrome","volume":"341","author":"Lacroix","year":"1999","journal-title":"N Engl J Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1210\/jc.2002-021292","article-title":"Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone","volume":"88","author":"Goodarzi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1210\/jc.2004-1256","article-title":"In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing\u2019s syndrome: identification of two cases of gonadotropin\/gastric inhibitory polypeptide-dependent hypercortisolism","volume":"90","author":"Bertherat","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B48","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1365-2265.2005.02387.x","article-title":"Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial ACTH-independent macronodular adrenal hyperplasia","volume":"63","author":"Lee","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1210\/en.2005-0921","article-title":"Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model","volume":"147","author":"Mazzuco","year":"2006","journal-title":"Endocrinology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1210\/jc.2005-1975","article-title":"Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing\u2019s syndrome features","volume":"91","author":"Mazzuco","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e1002700","DOI":"10.1371\/journal.pgen.1002700","article-title":"Acquisition order of Ras and p53 gene alterations defines distinct adrenocortical tumor phenotypes","volume":"8","author":"Herbet","year":"2012","journal-title":"PLoS Genet"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1245\/s10434-008-9981-3","article-title":"Extra-intestinal manifestations of familial adenomatous polyposis","volume":"15","author":"Groen","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.mce.2011.09.009","article-title":"Wnt\/\u03b2-catenin signalling in adrenal physiology and tumour development","volume":"351","author":"Berthon","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1530\/EJE-11-0679","article-title":"Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d\u2019etude des Tumeurs Endocrines database","volume":"166","author":"Gatta-Cherifi","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.juro.2012.07.139","article-title":"Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer","volume":"189","author":"Shuch","year":"2013","journal-title":"J Urol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-2265.2012.04366.x","article-title":"Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours","volume":"77","author":"Rothenbuhler","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"E2063","DOI":"10.1210\/jc.2012-2275","article-title":"Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors","volume":"97","author":"Vezzosi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B58","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.mce.2003.10.052","article-title":"Constitutive activation of the human ACTH receptor resulting from a synergistic interaction between two naturally occurring missense mutations in the MC2R gene","volume":"213","author":"Swords","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.mce.2013.08.022","article-title":"Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics","volume":"386","author":"Salpea","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/MPA.0b013e31829f9d3d","article-title":"Multiple endocrine neoplasia type 1 associated with a new mutation in the menin gene and a midgut neuroendocrine tumor","volume":"43","author":"Agarwal","year":"2014","journal-title":"Pancreas"},{"key":"B61","doi-asserted-by":"publisher","first-page":"E1113","DOI":"10.1210\/jc.2013-4280","article-title":"Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation","volume":"99","author":"Faucz","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B62","doi-asserted-by":"publisher","first-page":"E1784","DOI":"10.1210\/jc.2014-1265","article-title":"ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia","volume":"99","author":"Gagliardi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1210\/jcem.86.9.7903","article-title":"Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation","volume":"86","author":"Stratakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/79238","article-title":"Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex","volume":"26","author":"Kirschner","year":"2000","journal-title":"Nat Genet"},{"key":"B65","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1055\/s-0034-1385908","article-title":"Protein kinase A alterations in adrenocortical tumors","volume":"46","author":"Espiard","year":"2014","journal-title":"Horm Metab Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"27294","DOI":"10.1074\/jbc.M200302200","article-title":"Increased basal cAMP-dependent protein kinase activity inhibits the formation of mesoderm-derived structures in the developing mouse embryo","volume":"277","author":"Amieux","year":"2002","journal-title":"J Biol Chem"},{"key":"B67","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.mce.2008.10.045","article-title":"A transgenic mouse line with specific Cre recombinase expression in the adrenal cortex","volume":"300","author":"Lambert-Langlais","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.mce.2011.10.006","article-title":"The cAMP pathway and the control of adrenocortical development and growth","volume":"351","author":"de Joussineau","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1093\/hmg\/ddu265","article-title":"mTOR pathway is activated by PKA in adrenocortical cells and participates in vivo to apoptosis resistance in primary pigmented nodular adrenocortical disease (PPNAD)","volume":"23","author":"de Joussineau","year":"2014","journal-title":"Hum Mol Genet"},{"key":"B70","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1081\/ERC-200043735","article-title":"Clinical and molecular genetic studies of bilateral adrenal hyperplasias","volume":"30","author":"Bourdeau","year":"2004","journal-title":"Endocr Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1210\/jc.2005-1301","article-title":"Serial analysis of gene expression in adrenocortical hyperplasia caused by a germline PRKAR1A mutation","volume":"91","author":"Horvath","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B72","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1126\/science.1249480","article-title":"Activating hotspot L205R mutation in PRKACA and adrenal Cushing\u2019s syndrome","volume":"344","author":"Cao","year":"2014","journal-title":"Science"},{"key":"B73","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/ng.2956","article-title":"Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors","volume":"46","author":"Goh","year":"2014","journal-title":"Nat Genet"},{"key":"B74","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1126\/science.1252328","article-title":"Recurrent somatic mutations underlie corticotropin-independent Cushing\u2019s syndrome","volume":"344","author":"Sato","year":"2014","journal-title":"Science"},{"issue":"17","key":"B75","first-page":"5308","article-title":"Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity","volume":"63","author":"Bertherat","year":"2003","journal-title":"Cancer Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"E2093","DOI":"10.1210\/jc.2014-2152","article-title":"Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing\u2019s syndrome: a European multicentric study","volume":"99","author":"Di Dalmazi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B77","doi-asserted-by":"publisher","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-05-0593","article-title":"Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors","volume":"65","author":"Tissier","year":"2005","journal-title":"Cancer Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"B79","doi-asserted-by":"publisher","first-page":"R63","DOI":"10.1530\/JOE-14-0597","article-title":"An update on novel mechanisms of primary aldosteronism","volume":"224","author":"Zennaro","year":"2015","journal-title":"J Endocrinol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nat Genet"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e06315","DOI":"10.7554\/eLife.06315","article-title":"Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"Elife"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat Genet"},{"key":"B83","doi-asserted-by":"publisher","first-page":"11455","DOI":"10.1523\/JNEUROSCI.3153-05.2005","article-title":"Modifying the subunit composition of TASK channels alters the modulation of a leak conductance in cerebellar granule neurons","volume":"25","author":"Aller","year":"2005","journal-title":"J Neurosci"},{"key":"B84","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/sj.emboj.7601934","article-title":"Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis","volume":"27","author":"Heitzmann","year":"2008","journal-title":"EMBO J"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1523\/JNEUROSCI.5764-08.2009","article-title":"Glucose inhibition persists in hypothalamic neurons lacking tandem-pore K+ channels","volume":"29","author":"Guyon","year":"2009","journal-title":"J Neurosci"},{"key":"B86","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.mce.2015.09.011","article-title":"Potassium channels related to primary aldosteronism: expression similarities and differences between human and rat adrenals","volume":"417","author":"Chen","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/hmg\/ddt484","article-title":"WNT\/\u03b2-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production","volume":"23","author":"Berthon","year":"2014","journal-title":"Hum Mol Genet"},{"key":"B88","doi-asserted-by":"publisher","first-page":"19546","DOI":"10.1038\/srep19546","article-title":"Activating mutations in CTNNB1 in aldosterone producing adenomas","volume":"6","author":"\u00c5kerstr\u00f6m","year":"2016","journal-title":"Sci Rep"},{"key":"B89","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1055\/s-2007-981476","article-title":"The molecular pathogenesis of childhood adrenocortical tumors","volume":"39","author":"Almeida","year":"2007","journal-title":"Horm Metab Res"},{"key":"B90","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mce.2011.09.040","article-title":"Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults","volume":"351","author":"Faria","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"5133","DOI":"10.1158\/1078-0432.CCR-10-1497","article-title":"Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers","volume":"16","author":"Gaujoux","year":"2010","journal-title":"Clin Cancer Res"},{"key":"B92","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.mce.2011.12.008","article-title":"Association of adrenocortical carcinoma with familial cancer susceptibility syndromes","volume":"351","author":"Else","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1158\/1078-0432.CCR-08-1067","article-title":"Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling","volume":"15","author":"Giordano","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.mce.2011.09.042","article-title":"Insulin-like growth factor system on adrenocortical tumorigenesis","volume":"351","author":"Ribeiro","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0002-9440(10)63846-1","article-title":"Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis","volume":"162","author":"Giordano","year":"2003","journal-title":"Am J Pathol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"E119","DOI":"10.1210\/jc.2012-2198","article-title":"Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma","volume":"98","author":"Raymond","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B97","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1200\/JCO.2013.52.6863","article-title":"Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children\u2019s oncology group study","volume":"33","author":"Wasserman","year":"2015","journal-title":"J Clin Oncol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1242\/dev.021493","article-title":"Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex","volume":"135","author":"Kim","year":"2008","journal-title":"Development"},{"key":"B99","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1365-2265.2007.03033.x","article-title":"Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas","volume":"68","author":"Tadjine","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B100","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1158\/1078-0432.CCR-10-2006","article-title":"\u03b2-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma","volume":"17","author":"Gaujoux","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1093\/emboj\/18.21.5931","article-title":"Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene","volume":"18","author":"Harada","year":"1999","journal-title":"EMBO J"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddw136","article-title":"EZH2 is overexpressed in adrenocortical carcinoma and is associated with disease progression","author":"Drelon","year":"2016","journal-title":"Hum Mol Genet"},{"key":"B103","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4161\/epi.24532","article-title":"Multifaceted role of EZH2 in breast and prostate tumorigenesis: epigenetics and beyond","volume":"8","author":"Deb","year":"2013","journal-title":"Epigenetics"},{"key":"B104","first-page":"5358","article-title":"A cancer family syndrome in twenty-four kindreds","volume":"48","author":"Li","year":"1988","journal-title":"Cancer Res"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"key":"B106","doi-asserted-by":"publisher","first-page":"9330","DOI":"10.1073\/pnas.161479898","article-title":"An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma","volume":"98","author":"Ribeiro","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B107","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.1210\/jcem.86.10.7957","article-title":"An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors","volume":"86","author":"Latronico","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"B108","first-page":"6762","article-title":"Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors","volume":"61","author":"Gicquel","year":"2001","journal-title":"Cancer Res"},{"issue":"18","key":"B109","doi-asserted-by":"publisher","first-page":"8276","DOI":"10.1158\/0008-5472.CAN-10-2014","article-title":"Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers","volume":"70","author":"Ragazzon","year":"2010","journal-title":"Cancer Res"},{"key":"B110","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2004.11.006","article-title":"Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome","volume":"119","author":"Lang","year":"2004","journal-title":"Cell"},{"key":"B111","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2004.11.004","article-title":"Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome","volume":"119","author":"Olive","year":"2004","journal-title":"Cell"},{"key":"B112","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/hmg\/ddi011","article-title":"Urogenital and caudal dysgenesis in adrenocortical dysplasia (acd) mice is caused by a splicing mutation in a novel telomeric regulator","volume":"14","author":"Keegan","year":"2005","journal-title":"Hum Mol Genet"},{"key":"B113","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semcdb.2014.02.004","article-title":"SV40 TAg mouse models of cancer","volume":"27","author":"Colvin","year":"2014","journal-title":"Semin Cell Dev Biol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1210\/en.2005-1279","article-title":"Adrenocorticotropin-dependent changes in SF-1\/DAX-1 ratio influence steroidogenic genes expression in a novel model of glucocorticoid-producing adrenocortical cell lines derived from targeted tumorigenesis","volume":"147","author":"Ragazzon","year":"2006","journal-title":"Endocrinology"},{"key":"B115","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1158\/0008-5472.CAN-06-3767","article-title":"Gene expression profiling of childhood adrenocortical tumors","volume":"67","author":"West","year":"2007","journal-title":"Cancer Res"},{"key":"B116","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1210\/jc.2004-0942","article-title":"Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors","volume":"90","author":"Figueiredo","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B117","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.1038\/ncomms7302","article-title":"Genomic landscape of paediatric adrenocortical tumours","volume":"6","author":"Pinto","year":"2015","journal-title":"Nat Commun"},{"key":"B118","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1210\/edrv.18.3.0301","article-title":"Steroidogenic factor 1: a key determinant of endocrine development and function","volume":"18","author":"Parker","year":"1997","journal-title":"Endocr Rev"},{"key":"B119","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1478-1336-1-8","article-title":"SF-1 a key player in the development and differentiation of steroidogenic tissues","volume":"1","author":"Val","year":"2003","journal-title":"Nucl Recept"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1210\/jc.2009-2040","article-title":"Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults","volume":"95","author":"Almeida","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B121","doi-asserted-by":"publisher","first-page":"E161","DOI":"10.1210\/jc.2010-0653","article-title":"High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors","volume":"95","author":"Sbiera","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B122","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1210\/en.2004-1643","article-title":"Gonadotropin-induced adrenocortical neoplasia in NU\/J nude mice","volume":"146","author":"Bielinska","year":"2005","journal-title":"Endocrinology"},{"key":"B123","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1210\/en.2014-1088","article-title":"Vanin-1 inactivation antagonizes the development of adrenocortical neoplasia in Sf-1 transgenic mice","volume":"155","author":"Latre de Late","year":"2014","journal-title":"Endocrinology"},{"key":"B124","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/gcc.22267","article-title":"Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene","volume":"54","author":"Juhlin","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"B125","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nature11019","article-title":"ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner","volume":"485","author":"Hao","year":"2012","journal-title":"Nature"},{"key":"B126","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"key":"B127","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.mce.2014.12.014","article-title":"Adrenal cortex tissue homeostasis and zonation: a WNT perspective","volume":"408","author":"Drelon","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1210\/endo.141.9.7668","article-title":"Establishment and characterization of a human adrenocortical carcinoma xenograft model","volume":"141","author":"Logie","year":"2000","journal-title":"Endocrinology"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"deposited":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T08:47:09Z","timestamp":1470991629000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fendo.2016.00093\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,15]]},"references-count":128,"URL":"https:\/\/doi.org\/10.3389\/fendo.2016.00093","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,15]]}}}